Biodelivery Sciences International Inc Quick Ratio (BDSI) starting from the fourth quarter 2021 to fourth quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Biodelivery Sciences International Inc   (NASDAQ: BDSI)

Biodelivery Sciences International Inc 's Quick Ratio

BDSI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Biodelivery Sciences International Inc 's Cash & cash equivalent grew by 13.49 % in the Q4 2021 sequentially, faster than Current Liabilities, this led to improvement in Biodelivery Sciences International Inc 's Quick Ratio to 1.39, Quick Ratio remained below Biodelivery Sciences International Inc average.

Within Major Pharmaceutical Preparations industry 497 other companies have achieved higher Quick Ratio than Biodelivery Sciences International Inc in fourth quarter 2021. While Quick Ratio total ranking in the fourth quarter 2021 has deteriorated compared to the prior quarter from 685 to 2340.

Explain Quick Ratio?
How much Cash & cash equivalents BDSI´s has?
What are BDSI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BDSI Quick Ratio (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1		 (Dec 31 2020)
Q4
Y / Y Current Liabilities Change 55.44 % 45.4 % 12.82 % -10.42 % -1.85 %
Y / Y Cash & cash equivalent Change 2.43 % 0.53 % 31.69 % 64.89 % 74.66 %
Quick Ratio MRQ 1.39 1.3 1.88 2.13 2.11
BDSI's Total Ranking # 2340 # 685 # 1805 # 1487 # 1849
Seq. Current Liabilities Change 6.08 % 21.52 % 17.08 % 3 % -0.78 %
Seq. Cash & cash equivalent Change 13.49 % -15.97 % 2.93 % 4.35 % 11.39 %



Quick Ratio fourth quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 498
Healthcare Sector # 921
Overall Market # 2340


Quick Ratio Statistics
High Average Low
3.45 1.77 0.59
(Mar 31 2014)   (Mar 31 2018)




Financial Statements
Biodelivery Sciences International Inc 's Current Liabilities $ 82 Millions Visit BDSI's Balance sheet
Biodelivery Sciences International Inc 's Cash & cash equivalent $ 114 Millions Visit BDSI's Balance sheet
Source of BDSI's Sales Visit BDSI's Sales by Geography


Cumulative Biodelivery Sciences International Inc 's Quick Ratio

BDSI's Quick Ratio for the trailling 12 Months

BDSI Quick Ratio

 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months		 (Dec 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth 24.35 % 10.74 % 3.11 % 7.62 % 35.92 %
Y / Y Cash & cash equivalent TTM Growth 20.87 % 37.73 % 59.24 % 69.32 % 71.05 %
Quick Ratio TTM 1.62 1.8 1.99 1.93 1.67
Total Ranking TTM # 5617 # 5600 # 5585 # 1154 # 5615
Seq. Current Liabilities TTM Growth 11.79 % 10.78 % 3.34 % -2.83 % -0.44 %
Seq. Cash & cash equivalent TTM Growth 0.61 % 0.12 % 6.88 % 12.27 % 14.64 %

Quick ratio ranking by company, industry and sector >> Back to BDSI Financial Strength Comparisons >> Go to Compare BDSI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2021 to $82.38 millions, cumulative Quick Ratio decreased to 1.62 below the Biodelivery Sciences International Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 602 other companies have achieved higher Quick Ratio than Biodelivery Sciences International Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2021 from 5600 to 5617.

Explain Quick Ratio?
How much Cash & cash equivalents BDSI´s has?
What are BDSI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 603
Healthcare Sector # 1197
Within the Market # 5617


trailing twelve months Quick Ratio Statistics
High Average Low
2.73 1.82 0.82
(Dec. 30, 2014)   (Mar 31 2018)




Companies with similar Quick Ratio in the quarter ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2021 MRQ Cash & cash equivalentDec 31 2021 MRQ Current Liabilities
Sinovac Biotech Ltd  3.81 $ 11,619.760  Millions$ 3,051.714  Millions
Tuhura Biosciences Inc   3.79 $ 10.537  Millions$ 2.780  Millions
Inventiva S a   3.79 $ 96.939  Millions$ 25.595  Millions
Coya Therapeutics Inc   3.78 $ 4.340  Millions$ 1.148  Millions
Axsome Therapeutics Inc   3.75 $ 86.473  Millions$ 23.065  Millions
Mersana Therapeutics inc   3.74 $ 177.947  Millions$ 47.523  Millions
Notable Labs Ltd   3.72 $ 53.150  Millions$ 14.279  Millions
Arcturus Therapeutics Holdings Inc   3.72 $ 370.492  Millions$ 99.537  Millions
Sol gel Technologies Ltd   3.66 $ 43.242  Millions$ 11.830  Millions
Scisparc Ltd  3.60 $ 6.875  Millions$ 1.911  Millions
Tenax Therapeutics Inc   3.57 $ 5.584  Millions$ 1.564  Millions
Cytomx Therapeutics Inc   3.56 $ 305.226  Millions$ 85.650  Millions
Novabridge Biosciences  3.56 $ 671.220  Millions$ 188.557  Millions
Madrigal Pharmaceuticals Inc   3.54 $ 270.346  Millions$ 76.428  Millions
Sigilon Therapeutics Inc   3.54 $ 123.356  Millions$ 34.888  Millions
Esperion Therapeutics Inc   3.54 $ 259.333  Millions$ 73.352  Millions
Zymeworks Inc   3.52 $ 252.608  Millions$ 71.853  Millions
Inmed Pharmaceuticals Inc  3.47 $ 7.410  Millions$ 2.135  Millions
Palatin Technologies Inc   3.41 $ 47.326  Millions$ 13.864  Millions
Alnylam Pharmaceuticals Inc   3.40 $ 2,368.592  Millions$ 695.710  Millions
Ultragenyx Pharmaceutical Inc   3.39 $ 740.196  Millions$ 218.053  Millions
Summit Therapeutics Inc   3.34 $ 71.791  Millions$ 21.498  Millions
Nextcure Inc   3.33 $ 13.006  Millions$ 3.910  Millions
Aravive Inc   3.31 $ 59.424  Millions$ 17.941  Millions
Amicus Therapeutics inc   3.31 $ 482.496  Millions$ 145.975  Millions
Karyopharm Therapeutics Inc   3.29 $ 234.964  Millions$ 71.402  Millions
Vertex Pharmaceuticals Inc  3.29 $ 7,524.900  Millions$ 2,289.200  Millions
Vbi Vaccines Inc  3.28 $ 121.694  Millions$ 37.109  Millions
23andme Holding Co  3.26 $ 586.204  Millions$ 179.551  Millions
Amarin Corp Plcuk  3.26 $ 458.046  Millions$ 140.525  Millions

Date modified: 2026-09-08T15:10:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.